Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.
about
Current and emerging azole antifungal agentsEfficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosisComparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.Fungal infections: a growing threatReversible fluconazole resistance in Candida albicans: a potential in vitro model.Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assaysSusceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.The use of caspofungin in HIV-infected individuals.Azole resistance in Candida.Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.High-dose therapy with fluconazole > or = 800 mg day-1.Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases.Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans.
P2860
Q24550733-5B185010-DFB2-43A4-BD2F-A2043E55D98FQ28379262-2768807D-B30D-43A3-97A9-637F6E4FD18DQ33669219-636387A4-5A12-4279-A5D9-CD3AD237621FQ34404601-619EEC33-6864-4BA2-8C5C-B76E68077D75Q35133365-4CA4AE19-B22B-421A-9492-44C745CFEAEFQ36525340-19CF381A-D77B-4724-AB06-A3C6988116DDQ36528018-37935949-2ABD-41AA-8B94-126173A760E5Q36821383-DE4FB43A-DEF5-4512-89A0-ECE39B5D0261Q38970335-F45E3DFB-7E5A-4981-859E-CD34A2090132Q39782173-70510546-4721-4129-B23D-C6143360CB4DQ41708449-E35F1FAD-98AA-4231-985C-83E4456FC06FQ43299773-106B23FB-B0E1-4DCE-A83B-9E5A395A5DACQ51193892-7E3BB332-B637-48C4-963C-5AA8DE0816EDQ54033174-1445847E-2877-4DCA-B18B-B691283A40A9
P2860
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Azole resistance in oropharyng ...... human immunodeficiency virus.
@ast
Azole resistance in oropharyng ...... human immunodeficiency virus.
@en
type
label
Azole resistance in oropharyng ...... human immunodeficiency virus.
@ast
Azole resistance in oropharyng ...... human immunodeficiency virus.
@en
prefLabel
Azole resistance in oropharyng ...... human immunodeficiency virus.
@ast
Azole resistance in oropharyng ...... human immunodeficiency virus.
@en
P2093
P2860
P356
P1476
Azole resistance in oropharyng ...... human immunodeficiency virus.
@en
P2093
P2860
P304
P356
10.1128/AAC.38.10.2495
P407
P577
1994-10-01T00:00:00Z